(Q34435288)

2 August 2017

1 reference

title

Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis (English)

1 reference

2 August 2017

Casale TB

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

164

1 reference

2 August 2017

issue

8 Pt 2

1 reference

2 August 2017

page(s)

S18-21

1 reference

The impact of allergic rhinitis on bronchial asthma

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103023

Linking upper and lower airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103023

Allergic rhinobronchitis: the asthma-allergic rhinitis link

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103023

Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103023

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103023

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.SUPPLEMENT_1.2103023

10.1164/AJRCCM.164.SUPPLEMENT_1.2103023

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference